- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Interleukin-1 Receptor Antagonist as Therapy for Traumatic Brain Injury ; day:23 ; month:8 ; year:2023 ; pages:1-21
Neurotherapeutics ; (23.8.2023), 1-21
- Urheber
-
Lindblad, Caroline
Rostami, Elham
Helmy, Adel
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s13311-023-01421-0
- URN
-
urn:nbn:de:101:1-2023110609403211408988
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lindblad, Caroline
- Rostami, Elham
- Helmy, Adel
- SpringerLink (Online service)
Ähnliche Objekte (12)
Interleukin-1 receptor antagonist inhibits angiogenesis in gastric cancer
Production of interleukin-1 receptor antagonist by human articular chondrocytes
Anti-inflammatory properties of a novel peptide interleukin 1 receptor antagonist
Inflammation impacts androgen receptor signaling in basal prostate stem cells through interleukin 1 receptor antagonist
Neurosteroid Receptor Modulators for Treating Traumatic Brain Injury
Tumor-derived interleukin-1 receptor antagonist exhibits immunosuppressive functions and promotes pancreatic cancer
Rescued Chondrogenesis of Mesenchymal Stem Cells under Interleukin 1 Challenge by Foamyviral Interleukin 1 Receptor Antagonist Gene Transfer
Neuroprotective Effects of CXCR2 Antagonist SB332235 on Traumatic Brain Injury Through Suppressing NLRP3 Inflammasome
The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury
The role of Interleukin-1-Receptor-Antagonist in bladder cancer cell migration and invasion
Inhibition of inflammatory vasculopathic processes by interleukin-1 receptor antagonist, transduced endothelial progenitor cells
Interleukin 1 receptor antagonist relation to cardiovascular disease risk in patients with rheumatoid arthritis
Interleukin-1 receptor antagonist inhibits angiogenesis in gastric cancer
Production of interleukin-1 receptor antagonist by human articular chondrocytes
Anti-inflammatory properties of a novel peptide interleukin 1 receptor antagonist
Inflammation impacts androgen receptor signaling in basal prostate stem cells through interleukin 1 receptor antagonist
Neurosteroid Receptor Modulators for Treating Traumatic Brain Injury
Tumor-derived interleukin-1 receptor antagonist exhibits immunosuppressive functions and promotes pancreatic cancer
Rescued Chondrogenesis of Mesenchymal Stem Cells under Interleukin 1 Challenge by Foamyviral Interleukin 1 Receptor Antagonist Gene Transfer
Neuroprotective Effects of CXCR2 Antagonist SB332235 on Traumatic Brain Injury Through Suppressing NLRP3 Inflammasome
The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury
The role of Interleukin-1-Receptor-Antagonist in bladder cancer cell migration and invasion
Inhibition of inflammatory vasculopathic processes by interleukin-1 receptor antagonist, transduced endothelial progenitor cells
Interleukin 1 receptor antagonist relation to cardiovascular disease risk in patients with rheumatoid arthritis
Interleukin-1 receptor antagonist inhibits angiogenesis in gastric cancer
Production of interleukin-1 receptor antagonist by human articular chondrocytes
Anti-inflammatory properties of a novel peptide interleukin 1 receptor antagonist
Inflammation impacts androgen receptor signaling in basal prostate stem cells through interleukin 1 receptor antagonist
Neurosteroid Receptor Modulators for Treating Traumatic Brain Injury
Tumor-derived interleukin-1 receptor antagonist exhibits immunosuppressive functions and promotes pancreatic cancer
Rescued Chondrogenesis of Mesenchymal Stem Cells under Interleukin 1 Challenge by Foamyviral Interleukin 1 Receptor Antagonist Gene Transfer
Neuroprotective Effects of CXCR2 Antagonist SB332235 on Traumatic Brain Injury Through Suppressing NLRP3 Inflammasome
The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury
The role of Interleukin-1-Receptor-Antagonist in bladder cancer cell migration and invasion
Inhibition of inflammatory vasculopathic processes by interleukin-1 receptor antagonist, transduced endothelial progenitor cells